Depomed wins Nucynta patent dispute
September 30, 2016 at 17:16 PM EDT
Sept 30 (Reuters) - Depomed Inc said a court ruled in favor of the drug maker in a patent litigation over its opioid drug, Nucynta, extending its market exclusivity until 2025.
